These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33621616)

  • 1. How sensitive does chemical characterization of medical devices need to be? Calibration of analytical evaluation thresholds with the carcinogenic potency database.
    Kennedy TA; Spinti MJ
    Regul Toxicol Pharmacol; 2021 Jun; 122():104899. PubMed ID: 33621616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Analytical Strategy Based on Multiple Complementary and Orthogonal Chromatographic and Detection Methods (Multidetector Approach) to Effectively Manage the Analytical Evaluation Threshold (AET).
    Jordi M; Heise T
    PDA J Pharm Sci Technol; 2021; 75(3):289-301. PubMed ID: 33199517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.
    Jordi MA; Rowland K; Liu W; Cao X; Zong J; Ren Y; Liang Z; Zhou X; Louis M; Lerner K
    J Pharm Biomed Anal; 2020 Jul; 186():113334. PubMed ID: 32387747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Practical Derivation of the Uncertainty Factor Applied to Adjust the Extractables/Leachables Analytical Evaluation Threshold (AET) for Response Factor Variation.
    Jenke D; Christiaens P; Beusen JM; Verlinde P; Baeten J
    PDA J Pharm Sci Technol; 2022; 76(3):178-199. PubMed ID: 34782443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation.
    Jenke D; Heise T
    PDA J Pharm Sci Technol; 2021; 75(3):273-288. PubMed ID: 33199516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing.
    Kroes R; Galli C; Munro I; Schilter B; Tran L; Walker R; Würtzen G
    Food Chem Toxicol; 2000; 38(2-3):255-312. PubMed ID: 10717364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.
    Gold LS; Manley NB; Slone TH; Rohrbach L
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):527-600. PubMed ID: 10421768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of the Cancer Potency Database (CPDB) to enable derivations of Thresholds of Toxicological Concern (TTC) for cancer potency.
    Yang C; Rathman JF; Ribeiro JV; Batke M; Escher SE; Firman JW; Hobocienski B; Kellner R; Mostrag A; Przybylak KR; Cronin MTD
    Food Chem Toxicol; 2023 Dec; 182():114182. PubMed ID: 37951343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of TD
    Thresher A; Gosling JP; Williams R
    Toxicol Res (Camb); 2019 Sep; 8(5):696-703. PubMed ID: 31588346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(3):348-358. PubMed ID: 32295860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative factors in chemical carcinogenesis: variation in carcinogenic potency.
    Krewski D; Szyszkowicz M; Rosenkranz H
    Regul Toxicol Pharmacol; 1990 Aug; 12(1):13-29. PubMed ID: 2217915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of the TTC values for compounds that are genotoxic and/or carcinogenic and an approach for their re-evaluation.
    Boobis A; Brown P; Cronin MTD; Edwards J; Galli CL; Goodman J; Jacobs A; Kirkland D; Luijten M; Marsaux C; Martin M; Yang C; Hollnagel HM
    Crit Rev Toxicol; 2017 Sep; 47(8):705-727. PubMed ID: 28510487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety assessment and global regulatory requirements for genetic toxicity evaluations of medical devices.
    Przygoda RT
    Environ Mol Mutagen; 2017 Jun; 58(5):375-379. PubMed ID: 28573657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative assessment of extractables from single-use components and the impact of reference standard selection.
    Jordi MA; Khera S; Roland K; Jiang L; Solomon P; Nelson J; Lateef SS; Woods J; Martin L; Martin S; Aiello F; Chen N
    J Pharm Biomed Anal; 2018 Feb; 150():368-376. PubMed ID: 29287264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical Characterization and Non-targeted Analysis of Medical Device Extracts: A Review of Current Approaches, Gaps, and Emerging Practices.
    Sussman EM; Oktem B; Isayeva IS; Liu J; Wickramasekara S; Chandrasekar V; Nahan K; Shin HY; Zheng J
    ACS Biomater Sci Eng; 2022 Mar; 8(3):939-963. PubMed ID: 35171560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of the Threshold of Toxicological Concern (TTC) to Biological Evaluation of Medical Devices].
    Liu C; Shi Y; Du X; Sun X; Liu J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 Jul; 43(4):282-285. PubMed ID: 31460722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program.
    Gold LS; Slone TH; Manley NB; Garfinkel GB; Hudes ES; Rohrbach L; Ames BN
    Environ Health Perspect; 1991 Dec; 96():11-5. PubMed ID: 1820251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
    Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.